Condition: Pancreatic Cancer · Breast Cancer · Sponsor: Wake Forest University Health Sciences
The purpose of this study is to evaluate the feasibility of using a commercial WATD (Wearable Activity Tracker Device) to collect HRV (Heart Rate Variability) data from pancreatic and breast cancer patients.
This description comes directly from the study's public registry record.
Maggie Dzhanumova · 704-754-3768 · margarita.dzhanumova@advocatehealth.org
Always discuss trial participation with your own doctor first.
| Levine Cancer Institute | Charlotte, North Carolina, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06291324